NEW YORK (TheStreet) -- Leerink upgraded Wellcare (WCG - Get Report) to "outperform" from "market perform" and set a $74 target price. The firm cited valuation and noted the company has multiple potential catalysts.
The stock was up 1.65% to $66.40 at 9:33 a.m. on Thursday.
Must Read: Warren Buffett's 10 Favorite Stocks
- The revenue growth came in higher than the industry average of 10.4%. Since the same quarter one year prior, revenues rose by 22.7%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- The current debt-to-equity ratio, 0.40, is low and is below the industry average, implying that there has been successful management of debt levels. To add to this, WCG has a quick ratio of 2.08, which demonstrates the ability of the company to cover short-term liquidity needs.
- Compared to where it was 12 months ago, the stock is up, but it has so far lagged the appreciation in the S&P 500. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.
- WELLCARE HEALTH PLANS INC's earnings per share declined by 12.6% in the most recent quarter compared to the same quarter a year ago. Earnings per share have declined over the last two years. We anticipate that this should continue in the coming year. During the past fiscal year, WELLCARE HEALTH PLANS INC reported lower earnings of $3.98 versus $4.22 in the prior year. This year, the market expects earnings to be in line with last year ($3.98 versus $3.98).
- You can view the full analysis from the report here: WCG Ratings Report